Media Relations Media Releases First clinical guidelines in Canada for pain following spinal cord injury July 27, 2016 Research with impact in London nets almost $30 million in funding July 21, 2016 Research identifies unique needs of youth in the mental health treatment process July 5, 2016 Children’s nutrition influenced by local neighbourhoods June 21, 2016 Imaging study shows promising results for patients with schizophrenia May 27, 2016 Technology delivers personalized treatment to patients with tremors May 19, 2016 Eupraxia announces first patient dosed in phase I clinical trial of EP-104IAR to treat osteoarthritis-related pain May 17, 2016 London researchers first in Canada to use improved prostate cancer imaging May 9, 2016 First Canadian study demonstrates potential to remove patients from active liver transplant list after curing hepatitis C May 3, 2016 Celebrating research excellence and innovation April 13, 2016 First Page Icon Created with Sketch. First page « First Previous Page Icon Created with Sketch. Previous page ‹ Previous Elipsis Icon Created with Sketch. … Page 12 Page 13 Page 14 Page 15 Page 16 Page 17 Page 18 Current page 19 Page 20 Next Page Icon Created with Sketch. Next page Next › Last Page Icon Created with Sketch. Last page Last » 2022 Media Releases 2021 Media Releases 2020 Media Releases 2019 Media Releases 2018 Media Releases 2017 Media Releases 2016 Media Releases
Eupraxia announces first patient dosed in phase I clinical trial of EP-104IAR to treat osteoarthritis-related pain May 17, 2016
First Canadian study demonstrates potential to remove patients from active liver transplant list after curing hepatitis C May 3, 2016
November 23, 2022 Study aims to empower patients with Type 2 diabetes to take control of their health
